Simcere Pharmaceutical Articles
Bristol-Myers expands partnerships with Simcere and NeurOp
15 December 2011
Merck & Co sets up China marketing JV with Simcere
22 July 2011
Leadership changes at Eli Lilly, Pierre Fabre and China’s Simcere
14 February 2011
Bristol-Myers Squibb in deal to develop early-stage oncology compound with China’s Simcere; to buy back $750 million of debt
4 November 2010
Simcere’s Jiangsu Yanshen subsidiary disciplined and has rabies vaccine license revoked by SFDA
4 May 2010
Showing 1-7 of 7 articles
- 1
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
